# Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer

> **NCT00786552** · PHASE2 · UNKNOWN · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 47 (estimated)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DRUG:** pemetrexed + paclitaxel

## Key facts

- **NCT ID:** NCT00786552
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2012-11
- **Final completion:** 2013-11
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2011-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00786552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00786552, "Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00786552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*